On May 8, 2008, Malkinson & Halpern, P.C. filed a federal class action lawsuit in New Jersey on behalf of a Digitek patient, and all others similarly situated in the United States.

The suit was filed two weeks after the U.S. Food and Drug Administration (FDA) announced a complete recall of Digitek, a widely used heart medication. Digitek, manufactured by Actavis Totowa, is used by millions of people to improve heart beat strength or calm abnormal heart rhythms. The recall was instituted because of a manufacturing issue that had apparently resulted in tablets being distributed for consumption that contained up to twice the labeled dosage of the medicine.

Related Injuries. Excessive doses can lead to digitalis toxicity, resulting in nausea, vomiting, dizziness, low blood pressure, cardiac instability, bradycardia, and even death. Digitalis toxicity can also be associated with kidney failure.

Monetary Damages. Since the recall, many users of the medication have also likely undergone blood testing or other medical examinations to evaluate the amount of digitalis in their system. The lawsuit seeks damages to compensate users who were injured by the recalled medication, and Medical Monitoring to have the manufacturer compensate patients for all incidental medical costs.

For a free claims evaluation, please contact Malkinson & Halpern, P.C. if you or a loved one were taking the recalled Digitek pursuant to a prescription and have incurred expenses or suffered injuries as a result.